A new detailed analysis of a patient's second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical…
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
"I think the image of a cancer patient is an old, an older person who's frail," Natasha Allen said. "People don't think like 'oh, cancer,' then think of someone that looks like me. But right now that image is changing."
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, showed that…
Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a five-year study led by Houston Methodist researchers…
Expression of Gstt1 enables the cells to change the surrounding environment to support their growth. The findings could lead to new strategies to treat metastatic cancer and would be particularly impactful for patients with pancreatic…
(MedPage Today) -- A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial showed.
Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials. A new technique for 3D cell culturing, developed by researchers at…
There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May…
Lucille Thorne, 68, injured her knee after she slipped on the marble floor at a resort in the Maldives - where she had started her dream holiday - before going on a cruise.
On this episode of "The Founder CEO," Michael O'Neil, founder and CEO of GetWellNetwork, discusses his inspiring journey as a leader and the transformative role of AI in healthcare.
A comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer shows that FAPI PET/CT is more accurate in staging patients. Nearly 20 percent of patients were restaged by FAPI PET/CT,…